주식회사유피덴
주식회사유피덴's KOBDi Score is 40.91 as of Sep 2026, up 2.84 points since Apr 2025; it rose in 3 and fell in 2 of the 12 monthly updates. As of Sep 2026 it is ahead of about 47% of companies in its industry, against 48% in Aug 2026 and the lower 10% in Apr 2025. Its strongest position was 48% (Aug 2026) and its weakest the lower 10% (May 2025).
A year earlier, in Aug 2025, its score was 40.71 and it was ahead of about 17% of companies in its industry.
| Sep 2026 | 40.91 | ahead of 47% |
| Aug 2026 | 40.91 | ahead of 48% |
| Jul 2026 | 40.91 | ahead of 47% |
| Jun 2026 | 40.91 | ahead of 47% |
| May 2026 | 40.91 | ahead of 47% |
| Apr 2026 | 40.91 | ahead of 47% |
| Mar 2026 | 37.92 | ahead of 40% |
| Feb 2026 | 37.88 | ahead of 40% |
| Dec 2025 | 37.88 | ahead of 40% |
| Aug 2025 | 40.71 | ahead of 17% |
| Jul 2025 | 40.72 | ahead of 15% |
| May 2025 | 38.07 | lower 10% |
| Apr 2025 | 38.07 | lower 10% |
Where is 주식회사유피덴 located?
주식회사유피덴 is registered at 대구 북구 유통단지로8길, South Korea (postal code 41515).
What industry is 주식회사유피덴 in?
주식회사유피덴 belongs to Manufacturing › Pharmaceuticals & Biologics › Manufacturing of medical supplies and other medicine-related products.
How many employees does 주식회사유피덴 have?
주식회사유피덴 has 1–4 employees.
What is 주식회사유피덴's KOBDi Score?
40.91 as of September 2026, ahead of about 47% of companies in its industry.
Who are 주식회사유피덴's competitors?
Similar companies include 유림텍, Borami and 메타산업.

